Towards Healthcare
Host Cell Protein Testing Market Size Reaches USD 2.56 Billion in 2025

Host Cell Protein Testing Market Growth Fueled by New Product Approvals, USP Chapter Revisions & Biotech Investments in 2025

According to market projections, the global host cell protein testing market, valued at USD 2.37 billion in 2024, is anticipated to reach USD 5.19 billion by 2034, growing at a CAGR of 8.17% over the next decade. The growing demand for biologics and stringent regulatory policies drive the market. North America led the global market owing to the presence of key players and favorable government policies. 

  • Insight Code: 5865
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The host cell protein testing market is projected to reach USD 5.19 billion by 2034, growing at a CAGR of 8.17% from 2025 to 2034.

North America is leading the host cell protein testing market due to the presence of key players, favorable government support, and increasing investments.

The host cell protein testing market includes seven segments including by technology, by expression system, by product stage, by application, by end-use, by service type, and by region.

Some key players include Bio-Techne, GE Healthcare, and Pacific BioLabs.

Key trends include the growing demand for biologics, stringent regulatory policies, and advancements in genomic technologies.

The acceptable limit for host cell protein is below 100 ng/mg or 100 ppm.

Examples of HCPs that may remain in the desired pharmaceutical product include monoclonal antibodies, antibody-drug conjugates, therapeutic proteins, vaccines, and other protein-based biopharmaceuticals.

Clinicaltrials.gov, Food and Drug Administration, National Health Commission, Germany Trade & Invest